10 Unstoppable Stocks That Could Double Your Money
On April 16, Fundstrat’s Tom Lee joined 'Closing Bell' on CNBC to discuss what to expect from equity markets going forward.
Eledon Pharmaceuticals Inc. (ELDN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 6,293,282 | $19,383,309 | 0.62% | |
| 2. | Defilade Capital Jonathan Forman | 3,564,127 | $10,977,511 | +9% | 1.54% |
| 3. | Zimmer Partners Stuart J. Zimmer | 1,875,000 | $5,775,000 | -22% | 0.14% |
| 4. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 1,772,131 | $5,458,163 | -17% | 0.87% |
| 5. | Catalio Capital Management George Petrocheilos And R. Jacob Vogelstein | 1,639,816 | $5,050,633 | +31% | 1.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 75,431 | $0.00 | 220,460 | 2024-05-09 | Filing | |
| $0.00 | 821,121 | $0.00 | 2,633,679 | 2024-05-09 | Filing | |
| $0.00 | 1,031,385 | $0.00 | 3,361,803 | 2024-05-09 | Filing | |
| $0.00 | 86,341 | $0.00 | 145,029 | 2023-05-05 | Filing | |
| $0.00 | 837,146 | $0.00 | 1,812,558 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.60 | 103,200 | $2,229,120.00 | 73,650 | 2020-12-02 | Filing | |
| $27.02 | 27 | $729.54 | 199,973 | 2020-10-30 | Filing | |
| $26.64 | 12,942 | $344,829.24 | 187,058 | 2020-10-30 | Filing | |
| $1.91 | 1,914 | $3,658.42 | 88,662 | 2019-05-21 | Filing | |
| $1.96 | 7,623 | $14,953.28 | 90,576 | 2019-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,382,245 | $13,497,314 | 0% | |
| 2. | 3,293,134 | $10,142,853 | 0% | |
| 3. | 2,464,919 | $7,591,951 | 0.01% | |
| 4. | 1,791,783 | $5,520,050 | 0% | |
| 5. | 1,419,912 | $4,373,329 | 1.18% |
News See All
Eledon Pharmaceuticals to Present Updated Clinical Data for Tegoprubart at World Transplant Congress
Eledon Pharmaceuticals Inc. (NASDAQ:ELDN) is one of the stocks under $10 to buy now.
10 Stocks Under $10 to Buy Now
Earlier on July 1, Peter Kraus, Aperture Investors chairman and CEO, joined 'Squawk Box' on CNBC to suggest that the small and mid-cap area is a place for significant growth.
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to Eledon Pharmaceuticals first quarter 2023 earnings conference call. At this time, all lines are listen-only mode.
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Eledon Pharmaceuticals Fourth Quarter and Full-Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Eledon Pharmaceuticals, Inc. (ELDN) Fell Out Of Favor With Hedge Funds
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund Resource Center